[86] reported that RG7834, a novel oral HBV gene expression inhibitor, could decrease the amounts of viral proteins and reduce viremia. RG7834 is a small-molecule compound belonging to your dihydroquinolizinones chemical class just like RNAi but by another mechanism.This details will not be a substitute for professional medical information. Normall